US03475V1017
US03475V1017
AngioDynamics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 31.05.2026 | Q1 '26 28.02.2026 | Q4 '25 30.11.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 484.47M EUR | 478.72M EUR | 476.84M EUR | 515.52M EUR |
Enterprise Value | 438.3M EUR | 424.86M EUR | 439.03M EUR | 473.88M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -256x | -- | -- | -- |
Price to Sales | 1.49x | 1.5x | 1.52x | 2.19x |
Price to Book | 2.81x | 2.8x | 2.75x | 2.92x |
EV/Revenue | 1.35x | 1.33x | 1.4x | 2.01x |
EV/EBITDA | 141.84x | 23.31x | 24.65x | 39.08x |
Price to FCF (P/FCF) | 20.03x | 942.36x | 317.26x | 91.6x |
EV/FCF | 18.12x | 836.33x | 292.1x | 84.2x |
FCF Yield | 4.99% | 0.11% | 0.32% | 1.09% |